ALLERGIC ASTHMA

This study follows 225 adults with chronic spontaneous urticaria (long-term hives) or severe allergic asthma whose disease has been stable for at least 3 months on the original omalizumab. Their doctor has decided to switch them to a biosimilar version called Omlyclo®. The main g…

This study tests an experimental drug called LP-003 in about 200 adults with moderate to severe allergic asthma that is not well controlled. Participants will receive either LP-003, an active comparator, or a placebo to see if the drug reduces asthma flare-ups and improves lung f…

This study tests a new drug called FB825 for adults with moderate-to-severe allergic asthma. About 100 participants will receive either FB825 or a placebo to see if it reduces asthma attacks and improves breathing. The goal is to better control the disease, not cure it.

This study tests whether injecting a cat allergen directly into lymph nodes (instead of under the skin) is safe and tolerable for adults with cat allergy and asthma. About 36 participants will receive 3-4 ultrasound-guided injections and be monitored for allergic reactions and im…

This study is for adults with hay fever living in South-Eastern Australia. Researchers want to find out who is most at risk for thunderstorm asthma, a dangerous condition that happens during spring pollen season. Participants will be tested for grass pollen allergy, do simple bre…

This study looks at whether a simple skin test measuring histamine response can help doctors choose the right asthma medicine for children aged 6 to 17 with allergic asthma. About 300 children will receive either levocetirizine (an antihistamine) or a placebo for 6 weeks each, an…